15 Mar Director/PDMR Shareholding
Paris, France and Camberley, UK – 15 March 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on...
11 Mar Holdings in Company
Paris, France and Camberley, UK – 11 March 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex...
18 Feb Holdings in Company
Paris, France and Camberley, UK – 18 February 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex...
17 Feb Approval of the first direct-to-PCR COVID-19 test in the UK under CTDA legislation
Paris, France and Camberley, UK – 17 February 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s PROmate® COVID-19 2G Real-Time...
15 Feb Holdings in Company
Paris, France and Camberley, UK – 15 February 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex...
04 Feb Long Term Incentive Plan 2022 Performance Share Awards
Paris, France and Camberley, UK – 4 February 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it is launching a new...
25 Jan Strategy and Full Year 2021 Trading Update and Interview with David Allmond
Full year revenue and EBITDA in line with expectationsCommitted to becoming a leading, global clinical diagnostics company Paris, France and Camberley, UK – 25 January 2022 – Novacyt (EURONEXT GROWTH: ALNOV;...
30 Nov Unpredictable challenges for respiratory virus treatment
Posted at 11:09h
in Blog
Winter 2021/2022 could become the most challenging in decades for respiratory healthcare. There are many unknowns, such as the potential impact of circulating influenza or the trajectory of new COVID-19 variants...
26 Nov Approval of COVID-19 test in the UK under CTDA legislation
Posted at 07:00h
in Novacyt Group
Paris, France and Camberley, UK – 26 November 2021 – Novacyt (EURONEXTGROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics,announces that, further to the announcement on 2 November 2021,...
02 Nov Validation of COVID-19 tests in the UK under CTDA legislation
Posted at 07:11h
in Products
Paris, France and Camberley, UK – 2 November 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the availability of its...